Approach to growth hormone therapy in children with chronic kidney disease varies across North America: the Midwest Pediatric Nephrology Consortium report

Approach to growth hormone therapy in children with chronic kidney disease varies across North America: the Midwest Pediatric Nephrology Consortium report

Abstract Background Growth impairment remains common in children with chronic kidney disease (CKD). Available literature indicates low level of recombinant human growth hormone (rhGH) utilization in short children with CKD. Despite efforts at consensus guidelines, lack of high-level evidence continu...

Full description

Bibliographic Details
Main Authors: Oleh M. Akchurin, Amy J. Kogon, Juhi Kumar, Christine B. Sethna, Hoda T. Hammad, Paul J. Christos, John D. Mahan, Larry A. Greenbaum, Robert Woroniecki
Format: Article
Language:English
Published: BMC 2017-05-01
Series:BMC Nephrology
Subjects:
Short stature
Linear growth
Chronic kidney disease
Growth hormone
Standards of care
Survey
Online Access:http://link.springer.com/article/10.1186/s12882-017-0599-1

Internet

http://link.springer.com/article/10.1186/s12882-017-0599-1

Similar Items